CP-MVC-101-01
12 Apr 2022
Trial Summary
A Study of MVC-101 (Also Known as TAK-186) in Adults With Advanced or Metastatic Cancer
Acronym:
TAK-186
ACTRN/NCT /ethics:
NCT04844073
Scientific title:
A Study of MVC-101 (Also Known as TAK-186) in Adults With Advanced or Metastatic Cancer
Sponsor / Cooperative group:
Takeda
Trial & Patient Characteristics
| Cancer Type | All cancers |
|---|---|
| Trial Type | Treatment |
| Phase | Phase I; Phase II |
| Age Range | 18 years and older |
| Sex | All |
| Tumour Stream | - |
| Cancer Stage | Locally Advanced; Metastatic or Widespread |
| Anticipated Start Date | 2021-03-08 |
| Anticipated End Date | 2024-10-01 |
Participating Hospitals
| Hospital | Cancer Research SA |
|---|---|
| Clinical Trial Coordinator | Kelly Mead |
| admin@cancerresearchsa.com.au | |
| Phone | 08 8359 2565 |
| Principal Investigator | Dr Ganessan Kichenadasse |
| Recruitment Status | Recruiting |